sb 203580 has been researched along with rvx 208 in 1 studies
Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (rvx 208) | Trials (rvx 208) | Recent Studies (post-2010) (rvx 208) |
---|---|---|---|---|---|
3,489 | 4 | 1,137 | 92 | 13 | 89 |
Protein | Taxonomy | sb 203580 (IC50) | rvx 208 (IC50) |
---|---|---|---|
Bromodomain-containing protein 4 | Homo sapiens (human) | 1.629 | |
Bromodomain-containing protein 2 | Homo sapiens (human) | 2.9935 | |
Bromodomain-containing protein 3 | Homo sapiens (human) | 1.5467 | |
Bromodomain testis-specific protein | Homo sapiens (human) | 2.8167 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ayoub, AM; Berndt, N; Carlson, AS; Cui, H; Divakaran, A; Harki, DA; Mishra, NK; Pomerantz, WCK; Schonbrunn, EK; Talluri, SK; Topczewski, JJ; Widen, JC; Zhu, JY | 1 |
1 other study(ies) available for sb 203580 and rvx 208
Article | Year |
---|---|
Molecular Basis for the N-Terminal Bromodomain-and-Extra-Terminal-Family Selectivity of a Dual Kinase-Bromodomain Inhibitor.
Topics: A549 Cells; Humans; Imidazoles; p38 Mitogen-Activated Protein Kinases; Protein Domains; Protein Kinase Inhibitors; Water | 2018 |